lecture 8 Flashcards
what are the 3 approaches for treating the basic anion permeability defect in CF?
- genetic therapy
- CFTR modulator therapy
- alternate channel therapy
how muchCFTR function needs to be corrected?
-autosomal recessive- 50% function should be helpful
5% = lung disease
1% = pancreatic disease
how is a new therapy assessed in vivo?
endpoints to measure:
1. lung function (FEV1.0)
2. sweat chloride (sweat test)
parameters: hospitalisations, BMI & weight gain, quality of life
what 2 parts are sweat glands composed of?
- secretory coil
- reabsorptive duct epithelium
what is the secretory coil?
-embedded in skin
-primary secretion
-NaCl rich secretion from acinar (CC) cells
-Cl- secretion from TMEM16A (only some CFTR dependency)
-activated by beta-adrenergic stimulation
what is the reabsorptive duct epithelium?
-transcellular NaCl absorption = hypotonic fluid
-epithelium has low water permeability so water doesn’t move
-cells express both ENaC and CFTR and involved in NaCl absorption
how does ion and fluid transport in normal sweat glands occur?
-ENaC and CFTR present
-electrochemical gradient for Cl- moves down gradient driven by Na+ reabsorption
-leads to salt absorption but no water following
how does ion and fluid transport in CF sweat glands occur?
-don’t have ability to transport chloride
-loss of CFTR = prevents NaCl absorption = isotonic solution (120mM)
what is genetic therapy?
therapeutic approaches that:
-deliver copies of healthy gene using gene addition (DNA or mRNA)
-fix the chromosomal DNA using gene editing (CRISPR-CAS)
how was gene therapy first tested?
-put gene/code for CFTR into virus and get virus to infect the cells and reduce CFTR
what are the main problems with gene therapy?
physical and/or immune barriers
-body rejects the cells as recognises as being infected
what is the new approach to gene therapy?
-use liposome (bag of lipid) make it charged and mix with the cDNA for CFTR
-come together electrostaticly
-some gets into cell acne eventually makes CFTR
-inefficient - isn’t targeted
how can you improve the efficacy of gene therapy?
gene transfer agents:
-lentivirus - long term, stable correction as gene integrated into DNA
-modify virus to make them less immunogenic
-nanoparticles
what are the problems?
-need to target correct cells in lungs
-mucus is important barrier to gene therapy still
-potential for disruption of other genes
what are some other genetic and cell based approaches?
-mRNA vaccines